Skip to main content
Cancer Science logoLink to Cancer Science
. 2021 Jul 2;112(7):2932. doi: 10.1111/cas.15029

Erratum

PMCID: PMC8253275  PMID: 34214224

In an article 1 titled “Deubiquitinating enzyme inhibitor alleviates cyclin A1‐mediated proteasome inhibitor tolerance in mixed‐lineage leukemia” by Maolin Ge, Qiongyu Xu, Ting Kang, Dan Li, Ruiheng Wang, Zhihong Chen, Shufeng Xie, Wenbin Wang, and Han Liu, the below footnote should have appeared on the first page.

“Maolin Ge and Qiongyu Xu contributed equally to this work.”

The Publisher apologizes for the error.

REFERENCE

  • 1. Ge M, Xu Q, Kang T, et al. Deubiquitinating enzyme inhibitor alleviates cyclin A1‐mediated proteasome inhibitor tolerance in mixed‐lineage leukemia. Cancer Sci. 2021;112:2287‐2298. 10.1111/cas.14892 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancer Science are provided here courtesy of Wiley

RESOURCES